seen from Brazil
seen from United States
seen from United States
seen from Türkiye
seen from Canada
seen from Germany
seen from United States
seen from United States
seen from Japan
seen from Singapore
seen from United States
seen from United States
seen from Yemen
seen from India
seen from United States
seen from United States
seen from China
seen from United States
seen from United States
seen from United States
Weblinx lanza un nuevo sitio web para Southside Center of Hope Sitio web del Southside Center of Hope Weblinx, Inc. ha anunciado el lanzamiento de un nuevo sitio web para el recientemente nombrado Southside Center of Hope, formalmente St.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
OnDemand Webinar Now Available - Galectin-3 Treatment for Heart Failure
Dan Limbach
This webinar just became available as an OnDemand archive of the May 26, 2011 event. Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure
This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.
Complementary Webinar. Sponsored by BG Medicine.
View the webinar
Free Webinar: What are Galectins and how can they advance heart failure treatment?
Dan Limbach
Our next webinar will be on May 26 at 12:00pm EST. Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure
Register Now
This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.
Sponsored by BG Medicine and brought to you by PharmaVOICE.
Register Now
